Medtech Insight is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction

QUOTED. Aug. 31, 2018. Marc Scheineson.

Executive Summary

Medical app regulation has been a rapidly changing field and area of focus for US FDA over the last several years. Most recently, the agency approved the first direct-to-consumer app-based contraceptive, Natural Cycles. See what Marc Scheineson, an attorney and FDA vet who heads Alston & Bird’s food and drug law practice, said about the app here.

"Everybody's watching this. You can envision situations in which the mother may have some genetic predisposition to a serious disease or a birth defect and clearly not want to get pregnant. If she gets pregnant and she's using this, there are product liability cases based on wrongful death where someone is killed. But there can also be product liability cases based on wrongful life, where someone gives birth to an impaired child and they require medical services for an entire lifetime, and the parent can try to get damages based on that." –Marc Scheineson, attorney, Alson & Bird

Click here for a free trial of Medtech Insight

 

Related Content

Topics

Latest Headlines
See All
UsernamePublicRestriction

Register

MT123209

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel